Pegah Ebrahimi receives 29,104 Enovix (ENVX) RSUs as director pay
Rhea-AI Filing Summary
Ebrahimi Pegah reported acquisition or exercise transactions in this Form 4 filing.
Enovix Corp director Pegah Ebrahimi reported receiving a grant of 29,104 restricted stock units (RSUs), each representing one share of Enovix common stock. The RSUs were granted at $0.00 per share as part of equity compensation, not an open-market purchase.
The RSUs will vest in four equal installments of 25% on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the company’s 2027 annual stockholders’ meeting, subject to her continuous service as a director. After this award, she holds 102,043 shares of Enovix common stock, including shares underlying these RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 29,104 shares
Net Buy
1 txn
Insider
Ebrahimi Pegah
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 29,104 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 102,043 shares (Direct)
Footnotes (2)
- F1. 1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
- F2. Includes 29,104 shares issuable upon the settlement of RSUs granted to the Reporting Person.
Key Figures
RSUs granted: 29,104 RSUs
Grant price: $0.00 per share
Holdings after grant: 102,043 shares
+2 more
5 metrics
RSUs granted
29,104 RSUs
Equity award to director Pegah Ebrahimi on June 11, 2026
Grant price
$0.00 per share
Price per share for RSU grant
Holdings after grant
102,043 shares
Total Enovix common shares held following transaction
First vesting date
September 11, 2026
25% of RSUs vest on this date
Final vesting timeframe
June 11, 2027 or 2027 meeting
Last 25% of RSUs vest at earlier of this date or 2027 meeting
Key Terms
restricted stock units ("RSUs"), contingent right, vesting, continuous service
4 terms
restricted stock units ("RSUs") financial
"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
vesting financial
"25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each applicable vesting date."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Enovix (ENVX) director Pegah Ebrahimi report on this Form 4?
The Form 4 reports that director Pegah Ebrahimi received a grant of 29,104 restricted stock units from Enovix. These RSUs are part of her equity compensation and each unit represents a contingent right to receive one share of Enovix common stock.
How many Enovix RSUs were granted to Pegah Ebrahimi and at what price?
Pegah Ebrahimi was granted 29,104 restricted stock units of Enovix common stock at a price of $0.00 per share. This indicates a compensatory equity award, not an open-market purchase, with value tied to Enovix’s future share price.
What is the vesting schedule for Pegah Ebrahimi’s 29,104 Enovix RSUs?
The 29,104 Enovix RSUs vest in four 25% tranches on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual meeting. Vesting requires her continuous service as a director through each date.
Are Pegah Ebrahimi’s Enovix RSUs immediately exercisable or subject to conditions?
The Enovix RSUs are subject to vesting conditions and are not immediately deliverable as shares. Each restricted stock unit converts into one share of common stock only upon vesting, contingent on her continuous service as a director through each vesting date.
Does this Enovix Form 4 involve any open-market buying or selling by Pegah Ebrahimi?
No, the Form 4 reflects a grant or award acquisition of Enovix restricted stock units, coded as transaction type “A.” The price per share is $0.00, meaning it is an equity compensation award rather than an open-market purchase or sale of existing shares.